1997
- Moberg PJ, Doty RL. Olfactory function in Huntington’s disease patients and at-risk offspring. Internat J Neurosci, 1997 Jan; 89(1-2): 133-9.
- Bylsma FW, Moberg PJ, Doty RL, Brandt J. Odor identification in Huntington’s disease patients and asymptomatic gene carriers. J Neuropsychiat Clin Neurosci. 1997 Fall; 9(4): 598-600. (UPSIT)
2013
- Delmaire C, Dumas EM, Sharman MA, et al. The structural correlates of functional deficits in early huntington’s disease. Hum Brain Mapp. 2013 Sep;34(9):2141-53. doi: 10.1002/hbm.22055. (UPSIT)
- Scahill RI, Hobbs NZ, Say MJ., et al. Clinical impairment in premanifest and early Huntington’s disease is associated with regionally specific atrophy. Hum Brain Mapp. 2013 Mar;34(3):519-29. doi: 10.1002/hbm.21449. Epub 2011 Nov 18. PMID: 22102212; PMCID: PMC6869979. (UPSIT)
2017
- Doty RL. Olfactory dysfunction in neurodegenerative diseases: is there a common pathological substrate? Lancet Neurol. 2017 Jun;16(6):478-488. doi: 10.1016/S1474-4422(17)30123-0. (UPSIT)
2018
- Ahveninen LM, Stout JC, Georgiou-Karistianis N, Lorenzetti V, Glikmann-Johnston Y. Reduced amygdala volumes are related to motor and cognitive signs in Huntington’s disease: The IMAGE-HD study. Neuroimage Clin. 2018 Mar 22;18:881-887. doi: 10.1016/j.nicl.2018.03.027. eCollection 2018. (UPSIT)
2019
- Wilkes FA, Abaryan Z, Ching CRK, Gutman BA, Madsen SK, Walterfang M, Velakoulis D, Stout JC, Chua P, Egan GF, Thompson PM, Looi JCL, Georgiou-Karistianis N. Striatal morphology and neurocognitive dysfunction in Huntington disease: The IMAGE-HD study. Psychiatry Res Neuroimaging. 2019 Sep 30;291:1-8. doi: 10.1016/j.pscychresns.2019.07.003. Epub 2019 Jul 12. PMID: 31330407. (UPSIT)